TR200101336T2 - Combinations with a beta-agonist and another antidiabetic agent - Google Patents

Combinations with a beta-agonist and another antidiabetic agent

Info

Publication number
TR200101336T2
TR200101336T2 TR2001/01336T TR200101336T TR200101336T2 TR 200101336 T2 TR200101336 T2 TR 200101336T2 TR 2001/01336 T TR2001/01336 T TR 2001/01336T TR 200101336 T TR200101336 T TR 200101336T TR 200101336 T2 TR200101336 T2 TR 200101336T2
Authority
TR
Turkey
Prior art keywords
agonist
beta
combinations
antidiabetic agent
another antidiabetic
Prior art date
Application number
TR2001/01336T
Other languages
Turkish (tr)
Inventor
Robert Sanders Arch Jonathan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824790.1A external-priority patent/GB9824790D0/en
Priority claimed from GBGB9824789.3A external-priority patent/GB9824789D0/en
Priority claimed from GBGB9824791.9A external-priority patent/GB9824791D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200101336T2 publication Critical patent/TR200101336T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)

Abstract

Bir memelide, örnegin bir insanda diyabet mellitusun ve diyabet mellitus ile ilgili vakalarin tedavisi için, ihtiyaç duyan memeliye bir beta antagonisti ve baska bir antidiyabetik maddeden, etkili, toksik olmayan ve farmasötik olarak kabul edilebilir bir miktarda verilmesini içeren bir yöntem.A method for the treatment of diabetes mellitus and cases related to diabetes mellitus in a mammal, for example, in a human, comprising administering to the mammal in need in an effective, non-toxic and pharmaceutically acceptable amount.

TR2001/01336T 1998-11-11 1999-11-11 Combinations with a beta-agonist and another antidiabetic agent TR200101336T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9824790.1A GB9824790D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824789.3A GB9824789D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824791.9A GB9824791D0 (en) 1998-11-11 1998-11-11 Novel methods of treatment

Publications (1)

Publication Number Publication Date
TR200101336T2 true TR200101336T2 (en) 2001-11-21

Family

ID=27269550

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01336T TR200101336T2 (en) 1998-11-11 1999-11-11 Combinations with a beta-agonist and another antidiabetic agent

Country Status (15)

Country Link
EP (1) EP1128845A1 (en)
JP (1) JP2002529430A (en)
KR (1) KR20010075698A (en)
CN (1) CN1332638A (en)
AU (1) AU766928B2 (en)
BR (1) BR9915214A (en)
CA (1) CA2350062A1 (en)
CZ (1) CZ20011655A3 (en)
HK (1) HK1041201A1 (en)
HU (1) HUP0104388A3 (en)
IL (1) IL143004A0 (en)
NO (1) NO20012300L (en)
PL (1) PL348154A1 (en)
TR (1) TR200101336T2 (en)
WO (1) WO2000027434A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1911221A (en) 1999-12-23 2007-02-14 诺瓦提斯公司 Use of a hypoglycemic agent for treating impaired glucose metabolism
AU2007201729B2 (en) * 1999-12-23 2010-02-25 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
AU2382601A (en) * 1999-12-24 2001-07-09 Smithkline Beecham Plc Novel method of treatment
US20030018061A1 (en) * 2000-01-28 2003-01-23 Kohei Ogawa Novel remedies with the use of beta 3 agonist
AU2001252573A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel substituted tricyclic compounds
WO2001083452A1 (en) * 2000-04-28 2001-11-08 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds
WO2006132196A1 (en) * 2005-06-08 2006-12-14 Asahi Kasei Pharma Corporation NOVEL PHARMACEUTICAL COMPRISING β3 AGONIST
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69100282T3 (en) * 1990-02-09 2001-01-11 Pharmacia & Upjohn Co., Kalamazoo USE OF INSULIN-SENSITIZING ACTIVE SUBSTANCES FOR THE TREATMENT OF HYPERTONIA.
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US6037362A (en) * 1996-01-10 2000-03-14 Asahi Kasei Kogyo Kabushiki Kaisha Tricyclic compounds and drug compositions containing the same

Also Published As

Publication number Publication date
HUP0104388A3 (en) 2002-12-28
HK1041201A1 (en) 2002-07-05
AU1063400A (en) 2000-05-29
WO2000027434A1 (en) 2000-05-18
NO20012300L (en) 2001-07-03
CA2350062A1 (en) 2000-05-18
EP1128845A1 (en) 2001-09-05
BR9915214A (en) 2001-12-18
IL143004A0 (en) 2002-04-21
PL348154A1 (en) 2002-05-06
JP2002529430A (en) 2002-09-10
CN1332638A (en) 2002-01-23
NO20012300D0 (en) 2001-05-10
AU766928B2 (en) 2003-10-23
HUP0104388A2 (en) 2002-03-28
KR20010075698A (en) 2001-08-09
CZ20011655A3 (en) 2002-06-12

Similar Documents

Publication Publication Date Title
TR199903057T2 (en) Treatment of diabetes with thiazolidinedione and metformin.
MXPA02012763A (en) Combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabete mellitus.
TR200102977T2 (en) New treatment method.
YU37301A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
IT1302307B1 (en) COMPOSITION WITH ANTIOXIDANT ACTIVITY AND FOR IMPROVING THE METABOLIC USE OF GLUCOSE, INCLUDING ACETYL
TR200101336T2 (en) Combinations with a beta-agonist and another antidiabetic agent
TR200000134T2 (en) Treatment of diabetes (diabetes) with thiazolidinedione, insulin secretagogue and biguanide.
TR199903095T2 (en) Treatment of diabetes with rosiglitazone and insulin.
TR200503846T2 (en) Alternative use for modified release insulin sensitiser and use
AP2000001735A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor.
MY125855A (en) Treatment of diabetes with a thiazolidinedione and sulphonylurea
MY138246A (en) Treatment of diabetes with thiazolidione and sulphonylurea.
TR199903072T2 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase.
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
TR200000957T2 (en) The use of thiazolidinedione in the treatment of hyperglycemia
CO5150158A1 (en) NEW ANTIDIABETIC TREATMENT
TR200000958T2 (en) The use of thiazolidinedione in the treatment of hyperglycemia.
ECSP982592A (en) NEW METHOD OF TREATMENT V
AP1692A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.
ECSP982591A (en) NEW METHOD OF TREATMENT IV
ECSP982541A (en) NEW METHOD OF TREATMENT II
ECSP982593A (en) NEW METHOD OF TREATMENT VI